As one of the pharmaceutical industry's leading platforms for innovation, collaboration, and business development, the 24th CPHI China and the 19th PMEC China will take place at the Shanghai New International Expo Centre from June 16–18, 2026.
The biopharmaceutical industry is entering a new phase of growth and opportunity. As China's biopharmaceutical sector continues its evolution from a participant in global innovation to an industry leader, integrating the innovation, industrial, and value chains has become essential to unlocking the next stage of development. Strengthening these connections will help accelerate the industry's transition from local innovation to global impact.
01 Advancing Technology, Empowering the Entire Value Chain
At Booth C26, Hall N3 (Bioengineering Pavilion), Morimatsu will bring together its latest innovations and industry expertise to showcase intelligent solutions designed for the future of biopharmaceutical manufacturing.
Drawing on years of technical expertise and industry experience, we will showcase a range of advanced processes and breakthrough solutions—supported by more comprehensive solutions, strong value propositions, and high-quality services.
Total Laboratory Solution
Solid Preparation Process Solution
API Process Solution
Solid Preparation Process Solution
02 New Products, New Perspectives
With more than 50 years of expertise in bioreactor and fermentation technology, Bioengineering AG has remained at the forefront of innovation in global biomanufacturing. During the exhibition, we invite you to visit our booth and discover the engineering excellence and technological advancements built over decades of industry leadership. Senior product managers from Bioengineering AG will be on-site to introduce the latest product innovations, showcasing cutting-edge technologies and sharing insights into emerging industry trends.
In addition to presenting the core technologies and design features behind these new solutions, the team will provide practical perspectives drawn from real-world industry applications. This is a valuable opportunity for direct discussions with technical experts, knowledge sharing, and exploration of the latest developments in biomanufacturing.
Through the exchange of ideas, we build stronger industry connections. Through collaboration, we create new opportunities for growth.
This June, we look forward to welcoming you to Shanghai and meeting again along the Huangpu River.
About Morimatsu LifeSciences
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.
Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.
Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.
As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
